Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 16;14(16):1796.
doi: 10.3390/diagnostics14161796.

The Usage of Different Hyaluronic-Acid-Containing Artificial Tears and the Treatment Outcome of Intense Pulsed Light Therapy for Dry Eye Disease: A Retrospective Cohort Study

Affiliations

The Usage of Different Hyaluronic-Acid-Containing Artificial Tears and the Treatment Outcome of Intense Pulsed Light Therapy for Dry Eye Disease: A Retrospective Cohort Study

Chia-Yi Lee et al. Diagnostics (Basel). .

Abstract

In this study, we aimed to investigate the effect of different hyaluronic acid (HA)-containing artificial tears on dry eye disease (DED) treatment in combination with intense pulsed light (IPL) therapy. A retrospective cohort study was conducted, and the participants received IPL therapy and HA-containing artificial tears. There were 42 and 40 eyes in the 0.10% and 0.15% HA groups after selection, respectively. The main outcomes were the postoperative non-invasive tear break-up time (NITBUT), Schirmer II test results, ocular surface stain, and numbers of DED-related symptoms. A generalized linear model was utilized to produce the adjusted odds ratio (aOR) and 95% confidence interval (CI) of the main outcomes between groups. At the three-month follow-up, the NITBUT was significantly higher in the 0.15% HA group (p = 0.023), and the NITBUT recovery was also significantly better in the 0.15% HA group compared to the 0.10% HA group (p = 0.039). The multiple DED-related symptoms significantly correlated with no DED symptom improvement in both the 0.10% and 0.15% HA groups (both p < 0.05), while the low pre-treatment NITBUT was marginally related to no DED symptom improvement in the 0.10% HA group (p = 0.047). A low NITBUT and Schirmer II test result correlated with no DED symptom improvement in both the groups (all p < 0.05). In conclusion, the application of 0.10% and 0.15% HA-containing artificial tears revealed similar effects to IPL therapy for DED.

Keywords: Schirmer test; dry eye disease; hyaluronic acid; intense pulsed light; tear break-up time.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
The trend of non-invasive tear break-up times between the two groups. HA: hyaluronic acid; NITBUT: non-invasive tear break-up time. * denotes significant difference between the two groups. A better NITBUT recovery was found in the 0.15% HA group.
Figure 2
Figure 2
The trend of Schirmer II test results between the two groups. HA: hyaluronic acid. Similar improvements in the Schirmer II test result were found in the two groups.

Similar articles

References

    1. Clayton J.A. Dry Eye. N. Engl. J. Med. 2018;378:2212–2223. doi: 10.1056/NEJMra1407936. - DOI - PubMed
    1. Cai Y., Wei J., Zhou J., Zou W. Prevalence and Incidence of Dry Eye Disease in Asia: A Systematic Review and Meta-Analysis. Ophthalmic Res. 2022;65:647–658. doi: 10.1159/000525696. - DOI - PubMed
    1. Sheppard J., Shen Lee B., Periman L.M. Dry eye disease: Identification and therapeutic strategies for primary care clinicians and clinical specialists. Ann. Med. 2023;55:241–252. doi: 10.1080/07853890.2022.2157477. - DOI - PMC - PubMed
    1. Szczotka-Flynn L.B., Maguire M.G., Ying G.S., Lin M.C., Bunya V.Y., Dana R., Asbell P.A. Impact of Dry Eye on Visual Acuity and Contrast Sensitivity: Dry Eye Assessment and Management Study. Optom. Vis. Sci. 2019;96:387–396. doi: 10.1097/OPX.0000000000001387. - DOI - PMC - PubMed
    1. Pflugfelder S.C., Stern M.E. The cornea in keratoconjunctivitis sicca. Exp. Eye Res. 2020;201:108295. doi: 10.1016/j.exer.2020.108295. - DOI - PMC - PubMed

LinkOut - more resources